QGEN
$38.85
Qiagen N.V.
$.22
.57%
QGEN
Earnings Whisper ®
N/A
1st Quarter March 2019
Consensus:  $0.26
Revenue:  $354.97 Mil
Monday
May 6
4:00 PM ET
Score
Grade
Tweet Share Watch
Tweet Share Watch

What do you expect when QGEN reports earnings?
Beat
Meet
Miss

Where is QGEN's stock price going from here?
Up
Flat
Down
Stock chart of QGEN
Analysts
Summary of analysts' recommendations for QGEN
Score
Grade
Pivots
Resistance
$39.20
$39.04
$38.84

$38.68

Support
$38.48
$38.32
$38.12
Tweet
Growth
Description
Qiagen NV produces biomedical and genetic products, products for separating and purifying nucleic acids for gene-based drug screening, nucleic acid-based clinical diagnostics, genetic vaccination and gene therapy.
Peers
BiogenBluebird BioGilead SciencesAmgenNeurocrine BiosciencesSeattle GeneticsNovavaxRepligenSangamo TherapeuticsBio-Techne